Skip to main content
Sheila Arvikar, MD, Rheumatology, Boston, MA

SheilaArvikarMD

Rheumatology Boston, MA

Rheumatoid Arthritis & Related

Instructor in Medicine, Harvard Medical School/Massachusetts General Hospital

Dr. Arvikar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Arvikar's full profile

Already have an account?

  • Office

    Massachusetts General Hospital
    Yawkey 2c, 55 Fruit Street
    Boston, MA 02114
    Phone+1 617-726-7938

Summary

  • Dr. Sheila Arvikar is a rheumatologist in Boston, MA and is affiliated with Massachusetts General Hospital. She received her medical degree from UMass Chan Medical School and has been in practice 11 years. Her research and clinical practice focuses om rheumatoid arthritis & Lyme arthritis.

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Rheumatology, 2009 - 2011
  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Internal Medicine, 2006 - 2009
  • University of Massachusetts Medical School
    University of Massachusetts Medical SchoolClass of 2006

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2009 - 2026
  • NH State Medical License
    NH State Medical License 2021 - 2023
  • RI State Medical License
    RI State Medical License 2021 - 2022
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Scientist Development Award Rheumatology Research Foundation, 2015
  • Young Investigator Bone and Joint Initiative, 2013
  • Don Riggin Research Award Arthritis Foundation, 2012
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • Reconsider Post Lyme Disease Treatment Options, Study Says
    Reconsider Post Lyme Disease Treatment Options, Study SaysFebruary 1st, 2017

Professional Memberships